I am so utterly and deeply sorry to hear this news. My thoughts, strength and prayers are with the Duncan family and all his friends and loved ones. What a tragedy. Glioblastoma (like all cancer) is pure, unadulterated evil. We must keep striving for a cure for it.
Hello @theABTA researchers! Thank you for dedicating your career to us patients 💙 Please comment if you have a Twitter account so we can follow your journey and research projects, and maybe even learn from each other?! #BTSM
A year ago today I was unable to walk having suffered a stroke. Thanks to the mindset learned as an Olympian, 2 months later I was back running! Today I’m thankful to my family, friends, fans, and @mjp360 for the incredible support! #strokesurvivor#health#Olympics#motivation
Over the years I dabbled in different areas of immunology & virology. Some areas are filled with people who support each other's work while other areas are so cliquey and impenetrable. Science benefits when ideas come from ppl with diverse backgrounds. Let's welcome newcomers.
Congratulations to our postdoc Nourhan for winning second place for her poster on sex biased medulloblastoma immune regulation! @Yunlab7 @houstonmethodist
Summer science symposium at @HoustonMethodist. Congratulations to our interns Hannah Borland and Taha Ismail for doing a great job this summer! Postdoc Nourhan Abdelfatta presenting her exciting work on medulloblastoma immune regulation.@Yunlab7
As part of #NationalGirlfriendsDay, let's give a shoutout to the friends who always have our backs! My girlfriends aren’t just people I like to hang out with—though we do plenty of that—they’re a vital part of who I am and who I’ll keep becoming.
Great to host a quick visit from Nicole Willmarth @nwillmarth from ABTA @abta at TMC along with other AARN members Betty Kim @BettyKimLab, Martyn Sharpe @Yunlab7
Combination of encorafenib, binimetinib and cetuximab significantly improved overall survival in patients with BRAF-mutated metastatic #colorectalcancer.
Our @skopetz to present findings of Phase III BEACON clinical trial at #WorldGI2019: https://t.co/Gg7h7TQAgg #endcancer
Readers aged 18 to 25 can enter Nature’s essay competition. Tell us, in an essay of no more than 1,000 words, what scientific advance, big or small, you would most like to see in your lifetime. Deadline is Aug. 9. More details here: https://t.co/bedFmFvvMa
Our June 2019 issue is now live. Read about optimal design of and use of biomarkers in oncology trials, regulatory T cells, resistance to CAR T cell therapy and germline alterations in cancer: https://t.co/hjJU7i2ISR
Just learning to tweet 🤪 and apparently did not do this right the first time. Thank you @theABTA and Massimo @GlioVis and @CNIO_Cancer for an awesome trip. @AmericanCancer
Thank you ABTA for sponsoring my visit to Massimo Squatrito’s lab in Madrid! It’s been a very productive visit-learning new techniques, setting up new collaborations and working on our manuscript together.
Thank you ABTA for sponsoring my visit to Massimo Squatrito’s lab in Madrid! It’s been a very productive visit-learning new techniques, setting up new collaborations and working on our manuscript together.
Presented our ABTA-funded study “predictable and distinct mechanisms drive de novo vs. acquired resistance to SMO/SHH inhibitors in SHH medulloblastima” at Ped SNO in lovely San Francisco